Lymphedema Surveillance Study for Breast Cancer

Lymphedema Surveillance Study

Recruiting Observational Study
Breast Cancer Lymphedema
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
1,250 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Who this trial is looking for

This trial is looking for women over 18 who have breast cancer and will have surgery to remove lymph nodes. Participants will provide answers about their quality of life and allow tests on their breast tissue to help understand lymphedema risk.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a female breast cancer patient over the age of 18
  • I consent to have a unilateral axillary lymph node dissection
  • I can also participate if I consent to a sentinel lymph node biopsy
  • I self-identify as Black or White and consent to unilateral ALND or possible ALND

You may not be able to join if

  • I am a male breast cancer patient
  • I consent to bilateral axillary surgery
  • I have had surgery on one or more axillary lymph nodes more than 6 months ago
  • I have a prior history of axillary lymph node dissection
  • I have not had breast surgery at MSK

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others don't. Specifically, the investigators want to do tests on the breast tissue that is removed at the time of surgery to see if they can identify inflammation in the breast tissue, which may increase a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Female breast cancer patients over the age of 18 * Patients consenting for unilateral axillary lymph node dissection (ALND) (prior history of sentinel lymph node biopsy allowed if \<6 months from consent) * Patients consenting for unilateral sentinel lymph node biopsy (SLNB) a…
Contacts

Andrea Barrio, MD

646-888-5117

CONTACT

Babak Mehrara, MD

212-639-8639

CONTACT